{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifpsf44axa6moeq5xzh32wibd5i4rxv7wfhcn2pxmjry237f4egkq",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mphkvbklspq2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiabne5q74twx2w3krdc5syvblb4lku55imuanuwgifxibpca5xz4m"
    },
    "mimeType": "image/jpeg",
    "size": 91475
  },
  "path": "/2026/06/29/vijay-kumar-exits-fda-office-of-therapeutic-products/?utm_campaign=rss",
  "publishedAt": "2026-06-29T21:46:06.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Exclusive",
    "Pharma",
    "Politics",
    "biotechnology",
    "FDA",
    "Pharmaceuticals",
    "Policy",
    "STAT+"
  ],
  "textContent": "The departure of Vijay Kumar follows a broader leadership shakeup at the FDA.",
  "title": "STAT+: FDA’s top gene therapy regulator is leaving his role",
  "updatedAt": "2026-06-29T22:39:34.000Z"
}